Skip to main content
. 2012 Nov 27;54(3):401–408. doi: 10.1093/jrr/rrs113

Fig. 2.

Fig. 2.

Kaplan-Meier survival curve of esophageal squamous cell carcinoma (ESCC) patients sub-grouped as miRNA-22 negative or positive. (A) No difference was found between miRNA-22 expression and the overall survival of all 100 ESCC patients. (B) No difference was found between miRNA-22 expression and the overall survival of patients who received only chemotherapy. (C) Significant difference was found between miRNA-22 expression and the overall survival of patients who received concurrent chemotherapy with radiotherapy. The prognosis of miRNA-22 positive cases was significantly longer than that of miRNA-22 negative cases (P = 0.042).